📈 Economy · Next Month

Novo Nordisk A/S (CPH: NOVOB / NYSE: NVO) beats H1-2026 adjusted EPS consensus of approx. USD 5.31 per share (August 5, 2026, 07:30 CEST)

Hit ✦ AI-generated prediction Published on 22. July 2026 · Predicted for 5. August 2026 · Based on: Historical Cycle

Probability

72%

Novo Nordisk reports H1-2026 results on August 5 at 07:30 CEST. EPS consensus is $5.31; revenue consensus ~DKK 73.06B (Unusual Whales/MarketBeat, July 2026). Wegovy (semaglutide 2.4 mg) and Ozempic (semaglutide 1.0/2.0 mg) dominate the globally growing GLP-1 market. Novo has beaten EPS consensus in more than six consecutive quarters. Risks: US IRA negotiations on GLP-1 reimbursement, competition from Eli Lilly's tirzepatide, China price pressure. No specific prediction market.

Data basis for this prediction

Unusual Whales / MarketBeat: NVO H1-2026-EPS-Konsens 5,31 USD, Umsatzkonsens 73,06 Mrd. DKK (Jul 2026)
Novo Nordisk IR: H1-2026-Ergebnisankündigung für 5. August 2026, 07:30 Uhr CEST (novonordisk.com)
Capital.com / Meyka: Novo Nordisk konsistenter EPS-Beat-Track-Record, >6 Quartale in Folge (Jun/Jul 2026)

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit

Novo Nordisk hat beim H1-2026-Ergebnis (5. August 2026) den bereinigten EPS-Konsens klar übertroffen: tatsächliches adj. EPS ca. $0,96 je ADR vs. Zacks-Konsens $0,82 (Beat ~17%) bzw. $0,9527 vs. $0,7815 lt. Investing.com (Beat ~22%). Auch der Umsatzkonsens wurde übertroffen (DKK 78,49 Mrd. vs. ~DKK 73 Mrd.). Quellen: Investing.com-Transcript ('Novo Nordisk beats Q2 2026 estimates, shares rise premarket'), Tickeron-EPS-Recap, BioSpace/GlobeNewsWire-Pressemitteilung. Die Aktie fiel dennoch ~6%, da die Jahresguidance enttäuschte (Oral-Wegovy-Momentum, Guidance -6% bis 0% CER) – dies betrifft aber nicht den EPS-Beat selbst. Der in der Vorhersage genannte Wert von $5,31 entspricht dem annualisierten/FY-Konsens, nicht dem H1-spezifischen Quartalswert; die Richtungsaussage (Beat) war korrekt.

Related Predictions

📈 Economy ✦ AI

Take-Two Interactive (NASDAQ: TTWO) beats Q2 FY2027 EPS consensus of approx. -$0.45 per share — earnings report November 9, 2026 after close

Take-Two Interactive reports Q2 FY2027 (July–September 2026) results on November 9 after market close. Estimated analyst consensus: approx. -$0.45 EPS (heavy investment cycle around GTA VI and other AAA titles). TTWO has beaten consensus in 6 of the last 8 quarters; strong Recurrent Consumer Spending base (mobile, NBA 2K, GTA Online) consistently delivers positive surprises on cost discipline. Report date confirmed by TipRanks Earnings Calendar (as of Nov 8, 2026). Verification by TTWO Investor Relations or Bloomberg by November 10, 2026, 10:00 ET.

60%

Tomorrow · Predicted for 9. Nov 2026

📈 Economy ✦ AI

Constellation Energy (NASDAQ: CEG) beats Q3-FY2026 EPS consensus of $3.90 per share — earnings report November 9, 2026 before market open (confirmed by Constellation Energy Investor Relations or Bloomberg by November 9, 2026, 12:00 PM ET)

Constellation Energy reports Q3-FY2026 tomorrow (November 9, 2026) before market open. TradingView and Gurufocus put the EPS consensus at $3.90/share, with revenue consensus at $9.23B. CEG has beaten estimates in 7 of the last 8 quarters — an 87.5% historical beat rate. Driver: Structurally rising nuclear power demand for AI data centers (e.g., Microsoft contracts) boosts reactor utilization and secures stable cash flows. Risk: Stock fell ~9% post-midterm results, reflecting repriced regulatory uncertainty that could overshadow near-term operational strength. Strong fundamentals and consistent beat history nevertheless support another consensus beat.

68%

Tomorrow · Predicted for 9. Nov 2026

📈 Economy ✦ AI

Walmart Inc. (NYSE: WMT) beats Q3-FY2027 EPS consensus of $0.64 per share — earnings report November 19, 2026 before market open (confirmed by Walmart Investor Relations or Bloomberg by November 19, 2026, 12:00 PM ET)

Walmart has beaten EPS estimates for four consecutive quarters. The official consensus is $0.64/share — identical to the top of management guidance ($0.62–$0.64). Analysts average $0.72 (range $0.70–$0.73), anticipating another structural beat. Drivers: Robust US consumer (October CPI ~3.5–3.7%; September retail sales +0.8% MoM), ongoing grocery market share gains, and strong e-commerce and advertising growth. Risk: Management lowered full-year guidance after Q2; macro headwinds from elevated prices could compress volume mixes. The consistent beat history and structural tailwinds prevail.

65%

Next Month · Predicted for 19. Nov 2026